PPIs Linked to Higher Risk for Infection, Decompensation in Cirrhosis
Proton pump inhibitor (PPI) exposure is associated with an increased risk for infection and decompensation in patients with cirrhosis and with reduced all-cause mortality in those with previous gastrointestinal bleeding (GIB), according to a study…